Macrophage inflammatory response

The **macrophage inflammatory response** refers to the set of signaling pathways, cytokine production, and phenotypic changes initiated by macrophages when responding to stimuli such as microbial products, tissue damage, or cytokines. Macrophages can polarize toward a pro-inflammatory "M1" phenotype, characterized by production of TNF, IL-1β, IL-6, nitric oxide, and chemokines, as well as activation of signaling pathways including NF-κB, JAK/STAT, and MAPKs[1][4][5][6]. This response is essential for host defense and initiation of inflammation but is also tightly regulated, as excessive or prolonged activation can cause tissue damage or contribute to chronic inflammatory diseases[3][6]. Macrophages may also transition to an anti-inflammatory "M2" phenotype that promotes tissue repair and resolution of inflammation, driven by cytokines such as IL-4, IL-10, and TGF-β[5][7]. **Note:** If you are seeking a specific *molecule* or *receptor*—for example, "Toll-like receptor 4" (TLR4), "Interferon-gamma receptor" (IFNGR), or "Tumor necrosis factor receptor" (TNFR)—those are canonical targets involved in the macrophage inflammatory response[1][5][6][9]. However, as stated, "Macrophage inflammatory response" itself is not a discrete molecular entity or conventional drug target and is too broad for direct inclusion as a canonical therapeutic target.

Other names

Macrophage-mediated inflammatory responseInflammatory programming of macrophagesMacrophage activation in inflammation